Cargando…

Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis

OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Donghua, Duan, Ruoyu, Li, Chen, Xie, Zhiqun, Wang, Aihua, Xiong, Lili, Wei, Jianhui, Xi, Hui, Fang, Junqu, Yan, Huifang, Wang, Junyu, Zhang, Yu, Mao, Xiao, Wang, Jingmin, Wang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126321/
https://www.ncbi.nlm.nih.gov/pubmed/35615033
http://dx.doi.org/10.3389/fpubh.2022.887796
_version_ 1784712101071159296
author Xie, Donghua
Duan, Ruoyu
Li, Chen
Xie, Zhiqun
Wang, Aihua
Xiong, Lili
Wei, Jianhui
Xi, Hui
Fang, Junqu
Yan, Huifang
Wang, Junyu
Zhang, Yu
Mao, Xiao
Wang, Jingmin
Wang, Hua
author_facet Xie, Donghua
Duan, Ruoyu
Li, Chen
Xie, Zhiqun
Wang, Aihua
Xiong, Lili
Wei, Jianhui
Xi, Hui
Fang, Junqu
Yan, Huifang
Wang, Junyu
Zhang, Yu
Mao, Xiao
Wang, Jingmin
Wang, Hua
author_sort Xie, Donghua
collection PubMed
description OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on the details of diagnosis, as well as the direct medical cost, direct non-healthcare cost and indirect cost before and after receiving GD. We corrected the cost for time biases by calculating the cost per day for each patient. RESULTS: For the 502 patients with NDDs, the mean age was 4.08 ± 3.47. The household income was 0.6 (0.4, 1.0) 10,000 CNY per-month on average. The direct medical cost, direct non-healthcare cost and indirect cost were 12.27 (7.36, 22.23) 10,000 CNY, 1.45 (0.73, 2.69)10,000 CNY and 14.14(4.80, 28.25) 10,000 CNY per patient, respectively. Every patient received 1.20 (0.34, 3.60) 10,000 CNY on average (15.91%) from insurance. The daily total cost after receiving GD were ~62.48% lower than those before GD (191.59 CNY vs. 71.45 CNY). The descend range of lab cost (95.77%, P < 0.05) was the largest, followed by drugs (91.39%, P < 0.05), hospitalization (90.85%, P < 0.05), and consultation (57.41%, P < 0.05). The cost of rehabilitation kept slightly increasing but there were no significant differences (P > 0.05). The daily direct medical cost of each patient fell by 75.26% (P < 0.05) from 311.79 CNY to 77.14 CNY when the diagnostic age was younger than 1, and declined by 49.30% (P < 0.05) and 8.97% (P > 0.05) when the diagnostic age was 1–3 and older than 3, respectively. CONCLUSIONS: Early genetic diagnosis is crucial for to reducing the burden of disease because of the amount of money spent was lower when they are diagnosed at younger age. Patients with NDDs can incur a heavy economic burden, especially in rehabilitation cost and indirect cost, because the insurance coverage for patients is low, so it is urgent for governments to pay more attention to these issues.
format Online
Article
Text
id pubmed-9126321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91263212022-05-24 Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis Xie, Donghua Duan, Ruoyu Li, Chen Xie, Zhiqun Wang, Aihua Xiong, Lili Wei, Jianhui Xi, Hui Fang, Junqu Yan, Huifang Wang, Junyu Zhang, Yu Mao, Xiao Wang, Jingmin Wang, Hua Front Public Health Public Health OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on the details of diagnosis, as well as the direct medical cost, direct non-healthcare cost and indirect cost before and after receiving GD. We corrected the cost for time biases by calculating the cost per day for each patient. RESULTS: For the 502 patients with NDDs, the mean age was 4.08 ± 3.47. The household income was 0.6 (0.4, 1.0) 10,000 CNY per-month on average. The direct medical cost, direct non-healthcare cost and indirect cost were 12.27 (7.36, 22.23) 10,000 CNY, 1.45 (0.73, 2.69)10,000 CNY and 14.14(4.80, 28.25) 10,000 CNY per patient, respectively. Every patient received 1.20 (0.34, 3.60) 10,000 CNY on average (15.91%) from insurance. The daily total cost after receiving GD were ~62.48% lower than those before GD (191.59 CNY vs. 71.45 CNY). The descend range of lab cost (95.77%, P < 0.05) was the largest, followed by drugs (91.39%, P < 0.05), hospitalization (90.85%, P < 0.05), and consultation (57.41%, P < 0.05). The cost of rehabilitation kept slightly increasing but there were no significant differences (P > 0.05). The daily direct medical cost of each patient fell by 75.26% (P < 0.05) from 311.79 CNY to 77.14 CNY when the diagnostic age was younger than 1, and declined by 49.30% (P < 0.05) and 8.97% (P > 0.05) when the diagnostic age was 1–3 and older than 3, respectively. CONCLUSIONS: Early genetic diagnosis is crucial for to reducing the burden of disease because of the amount of money spent was lower when they are diagnosed at younger age. Patients with NDDs can incur a heavy economic burden, especially in rehabilitation cost and indirect cost, because the insurance coverage for patients is low, so it is urgent for governments to pay more attention to these issues. Frontiers Media S.A. 2022-05-09 /pmc/articles/PMC9126321/ /pubmed/35615033 http://dx.doi.org/10.3389/fpubh.2022.887796 Text en Copyright © 2022 Xie, Duan, Li, Xie, Wang, Xiong, Wei, Xi, Fang, Yan, Wang, Zhang, Mao, Wang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Xie, Donghua
Duan, Ruoyu
Li, Chen
Xie, Zhiqun
Wang, Aihua
Xiong, Lili
Wei, Jianhui
Xi, Hui
Fang, Junqu
Yan, Huifang
Wang, Junyu
Zhang, Yu
Mao, Xiao
Wang, Jingmin
Wang, Hua
Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title_full Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title_fullStr Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title_full_unstemmed Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title_short Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
title_sort study on the economic burden of neurodevelopmental diseases on patients with genetic diagnosis
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126321/
https://www.ncbi.nlm.nih.gov/pubmed/35615033
http://dx.doi.org/10.3389/fpubh.2022.887796
work_keys_str_mv AT xiedonghua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT duanruoyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT lichen studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT xiezhiqun studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT wangaihua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT xionglili studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT weijianhui studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT xihui studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT fangjunqu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT yanhuifang studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT wangjunyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT zhangyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT maoxiao studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT wangjingmin studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis
AT wanghua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis